Yesterdays article clearly said soon for Clinical Data...
Combined with potential clinical data being made available soon, this creates a number of catalysts for investors looking for a speculative play with a lot of upside.
You are confusing the Complete IND report that will be filed with FDA prior to Phase III with the Clinical data which could be released any day. Clinical data will show us how often Cypath successfully identified cancerous and pre-cancerous cells. This is the info that will validate BMOD's technology.